HOLLANDER DAVID (CMO & Global Therapeutics Lead) reported 2 transactions at REVANCE THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/6/2025ACC: 0000950170-25-015359
Officer· CMO & Global Therapeutics Lead
Since Feb 2024
-104.94K
Net shares
Net seller
$35.5K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
104.94K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−9.73K
Price / share
$3.65
Trade value
$35.53K
% of position
9.3%
2/4/2025
104.94K→95.21K
Common Stock
Direct
Shares
−95.21K
Price / share
—
Trade value
—
% of position
New position
2/6/2025
95.21K→0.00
Total
Net shares
−104.94K
Net value
-$35.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2025 | U · U | −9.73K | $3.65 | $35.53K | 9.3% | 104.94K | 95.21K |
| Common Stock Direct | 2/6/2025 | D · Disposition | −95.21K | — | — | New position | 95.21K | 0.00 |
| Total | −104.94K | -$35.53K | ||||||
Derivative Transactions0
No derivative transactions reported